Immune Response to Ovarian Cancer May Predict Survival, Mayo-Led Study Finds
Mayo ClinicA group of international cancer researchers led by investigators from Mayo Clinic and University of New South Wales Sydney has found that the level of a type of white blood cell, called tumor-infiltrating lymphocytes, present in the tumors of patients with high-grade ovarian cancer may predict a patient’s survival.